77 related articles for article (PubMed ID: 38530357)
1. Posttranslational protein modifications as gatekeepers of cancer immunogenicity.
Marchese E; Demehri S
J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747288
[TBL] [Abstract][Full Text] [Related]
2. Co-expression of immune checkpoints in glioblastoma revealed by single-nucleus RNA sequencing and spatial transcriptomics.
Yuan D; Chen W; Jin S; Li W; Liu W; Liu L; Wu Y; Zhang Y; He X; Jiang J; Sun H; Liu X; Liu J
Comput Struct Biotechnol J; 2024 Dec; 23():1534-1546. PubMed ID: 38633388
[TBL] [Abstract][Full Text] [Related]
3. Targeting CD73 and downstream adenosine receptor signaling in triple-negative breast cancer.
Allard B; Turcotte M; Stagg J
Expert Opin Ther Targets; 2014 Aug; 18(8):863-81. PubMed ID: 24798880
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy.
Kurago Z; Guo G; Shi H; Bollag RJ; Groves MW; Byrd JK; Cui Y
Front Immunol; 2023; 14():1212209. PubMed ID: 37435071
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological suppression of the OTUD4/CD73 proteolytic axis revives antitumor immunity against immune-suppressive breast cancers.
Zhu Y; Banerjee A; Xie P; Ivanov AA; Uddin A; Jiao Q; Chi JJ; Zeng L; Lee JY; Xue Y; Lu X; Cristofanilli M; Gradishar WJ; Henry CJ; Gillespie TW; Bhave MA; Kalinsky K; Fu H; Bahar I; Zhang B; Wan Y
J Clin Invest; 2024 Mar; 134(10):. PubMed ID: 38530357
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.
Song X; Zhou Z; Li H; Xue Y; Lu X; Bahar I; Kepp O; Hung MC; Kroemer G; Wan Y
Cancer Discov; 2020 Dec; 10(12):1872-1893. PubMed ID: 32938586
[TBL] [Abstract][Full Text] [Related]
7. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
Ma X; Wan R; Wen Y; Liu T; Song Y; Zhu Y
Exp Cell Res; 2024 Jan; 434(1):113864. PubMed ID: 38040050
[TBL] [Abstract][Full Text] [Related]
8. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer.
Xing Y; Ren ZQ; Jin R; Liu L; Pei JP; Yu K
Acta Pharmacol Sin; 2022 Sep; 43(9):2410-2418. PubMed ID: 35082394
[TBL] [Abstract][Full Text] [Related]
10. CD39/CD73/A2AR pathway and cancer immunotherapy.
Xia C; Yin S; To KKW; Fu L
Mol Cancer; 2023 Mar; 22(1):44. PubMed ID: 36859386
[TBL] [Abstract][Full Text] [Related]
11. Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity.
Fu Z; Chen S; Zhu Y; Zhang D; Xie P; Jiao Q; Chi J; Xu S; Xue Y; Lu X; Song X; Cristofanilli M; Gradishar WJ; Kalinsky K; Yin Y; Zhang B; Wan Y
Sci Adv; 2023 Jan; 9(1):eadd6626. PubMed ID: 36608132
[TBL] [Abstract][Full Text] [Related]
12. The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells.
Da M; Chen L; Enk A; Ring S; Mahnke K
Front Immunol; 2022; 13():914799. PubMed ID: 35711418
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic priming enhances antitumor immunity in platinum-resistant ovarian cancer.
Chen S; Xie P; Cowan M; Huang H; Cardenas H; Keathley R; Tanner EJ; Fleming GF; Moroney JW; Pant A; Akasha AM; Davuluri RV; Kocherginsky M; Zhang B; Matei D
J Clin Invest; 2022 Jul; 132(14):. PubMed ID: 35671108
[TBL] [Abstract][Full Text] [Related]
14. CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer.
Lin A; Qi C; Wei T; Li M; Cheng Q; Liu Z; Luo P; Zhang J
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35395670
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
